Report Detail
Global Gastrointestinal Therapeutics and Diagnostics Market Professional Survey Report 2019
- RnM3792880 |
- 30 September, 2019 |
- Global |
- 105 Pages |
- QYResearch |
- Pharma & Healthcare
Gastrointestinal disorders are related to digestive system and generally affect the colon, small & large intestine and rectum. The disorders include constipation, peptic ulcer diseases and irritable bowel syndrome. The major reason and cause of GI disorders are stress, intake of medicines such as iron pills and anti-depressants and unhealthy eating habits. Symptoms of the gastrointestinal infections include pain, bloating, diarrhea, nausea and vomiting. The major drugs that dominate the gastrointestinal diagnostics and therapeutics market are aciphex, afinitor, akynzeo, dificid and Prilosec.
The global Gastrointestinal Therapeutics and Diagnostics market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Gastrointestinal Therapeutics and Diagnostics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Gastrointestinal Therapeutics and Diagnostics market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Gastrointestinal Therapeutics and Diagnostics in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Gastrointestinal Therapeutics and Diagnostics manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Abbott Laboratories
Allergan
AstraZeneca
Bayer AG
GlaxoSmithKline
Janssen Pharmaceuticals
Takeda Pharmaceutical
Valeant Pharmaceuticals
Pfizer
AbbVie, Inc.
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Diagnostics
Therapeutics
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Table of Contents
Executive Summary
1 Industry Overview of Gastrointestinal Therapeutics and Diagnostics
- 1.1 Definition of Gastrointestinal Therapeutics and Diagnostics
- 1.2 Gastrointestinal Therapeutics and Diagnostics Segment by Type
- 1.2.1 Global Gastrointestinal Therapeutics and Diagnostics Production Growth Rate Comparison by Types (2014-2025)
- 1.2.2 Diagnostics
- 1.2.3 Therapeutics
- 1.3 Gastrointestinal Therapeutics and Diagnostics Segment by Applications
- 1.3.1 Global Gastrointestinal Therapeutics and Diagnostics Consumption Comparison by Applications (2014-2025)
- 1.3.2 Hospital Pharmacies
- 1.3.3 Retail Pharmacies
- 1.3.4 Online Pharmacies
- 1.4 Global Gastrointestinal Therapeutics and Diagnostics Overall Market
- 1.4.1 Global Gastrointestinal Therapeutics and Diagnostics Revenue (2014-2025)
- 1.4.2 Global Gastrointestinal Therapeutics and Diagnostics Production (2014-2025)
- 1.4.3 North America Gastrointestinal Therapeutics and Diagnostics Status and Prospect (2014-2025)
- 1.4.4 Europe Gastrointestinal Therapeutics and Diagnostics Status and Prospect (2014-2025)
- 1.4.5 China Gastrointestinal Therapeutics and Diagnostics Status and Prospect (2014-2025)
- 1.4.6 Japan Gastrointestinal Therapeutics and Diagnostics Status and Prospect (2014-2025)
- 1.4.7 Southeast Asia Gastrointestinal Therapeutics and Diagnostics Status and Prospect (2014-2025)
- 1.4.8 India Gastrointestinal Therapeutics and Diagnostics Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
- 2.1 Raw Material and Suppliers
- 2.2 Manufacturing Cost Structure Analysis of Gastrointestinal Therapeutics and Diagnostics
- 2.3 Manufacturing Process Analysis of Gastrointestinal Therapeutics and Diagnostics
- 2.4 Industry Chain Structure of Gastrointestinal Therapeutics and Diagnostics
3 Development and Manufacturing Plants Analysis of Gastrointestinal Therapeutics and Diagnostics
- 3.1 Capacity and Commercial Production Date
- 3.2 Global Gastrointestinal Therapeutics and Diagnostics Manufacturing Plants Distribution
- 3.3 Major Manufacturers Technology Source and Market Position of Gastrointestinal Therapeutics and Diagnostics
- 3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
- 4.1 Gastrointestinal Therapeutics and Diagnostics Production and Capacity Analysis
- 4.2 Gastrointestinal Therapeutics and Diagnostics Revenue Analysis
- 4.3 Gastrointestinal Therapeutics and Diagnostics Price Analysis
- 4.4 Market Concentration Degree
5 Gastrointestinal Therapeutics and Diagnostics Regional Market Analysis
- 5.1 Gastrointestinal Therapeutics and Diagnostics Production by Regions
- 5.1.1 Global Gastrointestinal Therapeutics and Diagnostics Production by Regions
- 5.1.2 Global Gastrointestinal Therapeutics and Diagnostics Revenue by Regions
- 5.2 Gastrointestinal Therapeutics and Diagnostics Consumption by Regions
- 5.3 North America Gastrointestinal Therapeutics and Diagnostics Market Analysis
- 5.3.1 North America Gastrointestinal Therapeutics and Diagnostics Production
- 5.3.2 North America Gastrointestinal Therapeutics and Diagnostics Revenue
- 5.3.3 Key Manufacturers in North America
- 5.3.4 North America Gastrointestinal Therapeutics and Diagnostics Import and Export
- 5.4 Europe Gastrointestinal Therapeutics and Diagnostics Market Analysis
- 5.4.1 Europe Gastrointestinal Therapeutics and Diagnostics Production
- 5.4.2 Europe Gastrointestinal Therapeutics and Diagnostics Revenue
- 5.4.3 Key Manufacturers in Europe
- 5.4.4 Europe Gastrointestinal Therapeutics and Diagnostics Import and Export
- 5.5 China Gastrointestinal Therapeutics and Diagnostics Market Analysis
- 5.5.1 China Gastrointestinal Therapeutics and Diagnostics Production
- 5.5.2 China Gastrointestinal Therapeutics and Diagnostics Revenue
- 5.5.3 Key Manufacturers in China
- 5.5.4 China Gastrointestinal Therapeutics and Diagnostics Import and Export
- 5.6 Japan Gastrointestinal Therapeutics and Diagnostics Market Analysis
- 5.6.1 Japan Gastrointestinal Therapeutics and Diagnostics Production
- 5.6.2 Japan Gastrointestinal Therapeutics and Diagnostics Revenue
- 5.6.3 Key Manufacturers in Japan
- 5.6.4 Japan Gastrointestinal Therapeutics and Diagnostics Import and Export
- 5.7 Southeast Asia Gastrointestinal Therapeutics and Diagnostics Market Analysis
- 5.7.1 Southeast Asia Gastrointestinal Therapeutics and Diagnostics Production
- 5.7.2 Southeast Asia Gastrointestinal Therapeutics and Diagnostics Revenue
- 5.7.3 Key Manufacturers in Southeast Asia
- 5.7.4 Southeast Asia Gastrointestinal Therapeutics and Diagnostics Import and Export
- 5.8 India Gastrointestinal Therapeutics and Diagnostics Market Analysis
- 5.8.1 India Gastrointestinal Therapeutics and Diagnostics Production
- 5.8.2 India Gastrointestinal Therapeutics and Diagnostics Revenue
- 5.8.3 Key Manufacturers in India
- 5.8.4 India Gastrointestinal Therapeutics and Diagnostics Import and Export
6 Gastrointestinal Therapeutics and Diagnostics Segment Market Analysis (by Type)
- 6.1 Global Gastrointestinal Therapeutics and Diagnostics Production by Type
- 6.2 Global Gastrointestinal Therapeutics and Diagnostics Revenue by Type
- 6.3 Gastrointestinal Therapeutics and Diagnostics Price by Type
7 Gastrointestinal Therapeutics and Diagnostics Segment Market Analysis (by Application)
- 7.1 Global Gastrointestinal Therapeutics and Diagnostics Consumption by Application
- 7.2 Global Gastrointestinal Therapeutics and Diagnostics Consumption Market Share by Application (2014-2019)
8 Gastrointestinal Therapeutics and Diagnostics Major Manufacturers Analysis
- 8.1 Abbott Laboratories
- 8.1.1 Abbott Laboratories Gastrointestinal Therapeutics and Diagnostics Production Sites and Area Served
- 8.1.2 Abbott Laboratories Product Introduction, Application and Specification
- 8.1.3 Abbott Laboratories Gastrointestinal Therapeutics and Diagnostics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.1.4 Main Business and Markets Served
- 8.2 Allergan
- 8.2.1 Allergan Gastrointestinal Therapeutics and Diagnostics Production Sites and Area Served
- 8.2.2 Allergan Product Introduction, Application and Specification
- 8.2.3 Allergan Gastrointestinal Therapeutics and Diagnostics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.2.4 Main Business and Markets Served
- 8.3 AstraZeneca
- 8.3.1 AstraZeneca Gastrointestinal Therapeutics and Diagnostics Production Sites and Area Served
- 8.3.2 AstraZeneca Product Introduction, Application and Specification
- 8.3.3 AstraZeneca Gastrointestinal Therapeutics and Diagnostics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.3.4 Main Business and Markets Served
- 8.4 Bayer AG
- 8.4.1 Bayer AG Gastrointestinal Therapeutics and Diagnostics Production Sites and Area Served
- 8.4.2 Bayer AG Product Introduction, Application and Specification
- 8.4.3 Bayer AG Gastrointestinal Therapeutics and Diagnostics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.4.4 Main Business and Markets Served
- 8.5 GlaxoSmithKline
- 8.5.1 GlaxoSmithKline Gastrointestinal Therapeutics and Diagnostics Production Sites and Area Served
- 8.5.2 GlaxoSmithKline Product Introduction, Application and Specification
- 8.5.3 GlaxoSmithKline Gastrointestinal Therapeutics and Diagnostics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.5.4 Main Business and Markets Served
- 8.6 Janssen Pharmaceuticals
- 8.6.1 Janssen Pharmaceuticals Gastrointestinal Therapeutics and Diagnostics Production Sites and Area Served
- 8.6.2 Janssen Pharmaceuticals Product Introduction, Application and Specification
- 8.6.3 Janssen Pharmaceuticals Gastrointestinal Therapeutics and Diagnostics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.6.4 Main Business and Markets Served
- 8.7 Takeda Pharmaceutical
- 8.7.1 Takeda Pharmaceutical Gastrointestinal Therapeutics and Diagnostics Production Sites and Area Served
- 8.7.2 Takeda Pharmaceutical Product Introduction, Application and Specification
- 8.7.3 Takeda Pharmaceutical Gastrointestinal Therapeutics and Diagnostics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.7.4 Main Business and Markets Served
- 8.8 Valeant Pharmaceuticals
- 8.8.1 Valeant Pharmaceuticals Gastrointestinal Therapeutics and Diagnostics Production Sites and Area Served
- 8.8.2 Valeant Pharmaceuticals Product Introduction, Application and Specification
- 8.8.3 Valeant Pharmaceuticals Gastrointestinal Therapeutics and Diagnostics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.8.4 Main Business and Markets Served
- 8.9 Pfizer
- 8.9.1 Pfizer Gastrointestinal Therapeutics and Diagnostics Production Sites and Area Served
- 8.9.2 Pfizer Product Introduction, Application and Specification
- 8.9.3 Pfizer Gastrointestinal Therapeutics and Diagnostics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.9.4 Main Business and Markets Served
- 8.10 AbbVie, Inc.
- 8.10.1 AbbVie, Inc. Gastrointestinal Therapeutics and Diagnostics Production Sites and Area Served
- 8.10.2 AbbVie, Inc. Product Introduction, Application and Specification
- 8.10.3 AbbVie, Inc. Gastrointestinal Therapeutics and Diagnostics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.10.4 Main Business and Markets Served
9 Development Trend of Analysis of Gastrointestinal Therapeutics and Diagnostics Market
- 9.1 Global Gastrointestinal Therapeutics and Diagnostics Market Trend Analysis
- 9.1.1 Global Gastrointestinal Therapeutics and Diagnostics Market Size (Volume and Value) Forecast 2019-2025
- 9.2 Gastrointestinal Therapeutics and Diagnostics Regional Market Trend
- 9.2.1 North America Gastrointestinal Therapeutics and Diagnostics Forecast 2019-2025
- 9.2.2 Europe Gastrointestinal Therapeutics and Diagnostics Forecast 2019-2025
- 9.2.3 China Gastrointestinal Therapeutics and Diagnostics Forecast 2019-2025
- 9.2.4 Japan Gastrointestinal Therapeutics and Diagnostics Forecast 2019-2025
- 9.2.5 Southeast Asia Gastrointestinal Therapeutics and Diagnostics Forecast 2019-2025
- 9.2.6 India Gastrointestinal Therapeutics and Diagnostics Forecast 2019-2025
- 9.3 Gastrointestinal Therapeutics and Diagnostics Market Trend (Product Type)
- 9.4 Gastrointestinal Therapeutics and Diagnostics Market Trend (Application)
- 10.1 Marketing Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.3 Gastrointestinal Therapeutics and Diagnostics Customers
11 Market Dynamics
- 11.1 Market Trends
- 11.2 Opportunities
- 11.3 Market Drivers
- 11.4 Challenges
- 11.5 Influence Factors
12 Conclusion
13 Appendix
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Summary:
Get latest Market Research Reports on Gastrointestinal Therapeutics and Diagnostics. Industry analysis & Market Report on Gastrointestinal Therapeutics and Diagnostics is a syndicated market report, published as Global Gastrointestinal Therapeutics and Diagnostics Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Gastrointestinal Therapeutics and Diagnostics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
